Annual CFO
-$118.69 M
+$19.63 M+14.19%
December 31, 2023
Summary
- As of February 7, 2025, ADCT annual cash flow from operations is -$118.69 million, with the most recent change of +$19.63 million (+14.19%) on December 31, 2023.
- During the last 3 years, ADCT annual CFO has risen by +$50.04 million (+29.66%).
- ADCT annual CFO is now -58.36% below its all-time high of -$74.94 million, reached on December 31, 2017.
Performance
ADCT Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$25.04 M
+$7.80 M+23.75%
September 30, 2024
Summary
- As of February 7, 2025, ADCT quarterly cash flow from operations is -$25.04 million, with the most recent change of +$7.80 million (+23.75%) on September 30, 2024.
- Over the past year, ADCT quarterly CFO has increased by +$6.59 million (+20.83%).
- ADCT quarterly CFO is now -1240.91% below its all-time high of $2.19 million, reached on September 30, 2022.
Performance
ADCT Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$133.62 M
+$11.63 M+8.01%
September 30, 2024
Summary
- As of February 7, 2025, ADCT TTM cash flow from operations is -$133.62 million, with the most recent change of +$11.63 million (+8.01%) on September 30, 2024.
- Over the past year, ADCT TTM CFO has dropped by -$14.93 million (-12.58%).
- ADCT TTM CFO is now -316.22% below its all-time high of -$32.10 million, reached on March 1, 2020.
Performance
ADCT TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
ADCT Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +14.2% | +20.8% | -12.6% |
| 3 y3 years | +29.7% | +59.4% | +42.8% |
| 5 y5 years | +2.2% | +59.4% | +42.8% |
ADCT Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +49.1% | -1240.9% | +59.4% | -31.3% | +42.8% |
| 5 y | 5-year | at high | +49.1% | -1240.9% | +59.4% | -316.2% | +42.8% |
| alltime | all time | -58.4% | +49.1% | -1240.9% | +59.4% | -316.2% | +42.8% |
ADC Therapeutics SA Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$25.04 M(-23.8%) | -$133.62 M(-8.0%) |
| Jun 2024 | - | -$32.84 M(-25.5%) | -$145.25 M(-1.5%) |
| Mar 2024 | - | -$44.09 M(+39.4%) | -$147.39 M(+24.2%) |
| Dec 2023 | -$118.69 M(-14.2%) | -$31.63 M(-13.7%) | -$118.69 M(-15.6%) |
| Sep 2023 | - | -$36.67 M(+4.8%) | -$140.67 M(+38.2%) |
| Jun 2023 | - | -$34.99 M(+127.3%) | -$101.80 M(-15.0%) |
| Mar 2023 | - | -$15.39 M(-71.3%) | -$119.82 M(-13.4%) |
| Dec 2022 | -$138.31 M(-40.7%) | -$53.61 M(-2542.6%) | -$138.31 M(-5.5%) |
| Sep 2022 | - | $2.19 M(-104.1%) | -$146.33 M(-29.3%) |
| Jun 2022 | - | -$53.01 M(+56.5%) | -$207.11 M(-2.4%) |
| Mar 2022 | - | -$33.88 M(-45.0%) | -$212.11 M(-9.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$233.38 M(+38.3%) | -$61.63 M(+5.2%) | -$233.38 M(+4.4%) |
| Sep 2021 | - | -$58.59 M(+1.0%) | -$223.44 M(+6.8%) |
| Jun 2021 | - | -$58.01 M(+5.2%) | -$209.14 M(+9.1%) |
| Mar 2021 | - | -$55.15 M(+6.7%) | -$191.78 M(+13.7%) |
| Dec 2020 | -$168.73 M(+38.8%) | -$51.69 M(+16.7%) | -$168.73 M(+44.2%) |
| Sep 2020 | - | -$44.29 M(+9.0%) | -$117.03 M(+60.9%) |
| Jun 2020 | - | -$40.65 M(+26.6%) | -$72.75 M(+126.6%) |
| Mar 2020 | - | -$32.10 M | -$32.10 M |
| Dec 2019 | -$121.58 M(+0.2%) | - | - |
| Dec 2018 | -$121.36 M(+61.9%) | - | - |
| Dec 2017 | -$74.94 M | - | - |
FAQ
- What is ADC Therapeutics SA annual cash flow from operations?
- What is the all time high annual CFO for ADC Therapeutics SA?
- What is ADC Therapeutics SA annual CFO year-on-year change?
- What is ADC Therapeutics SA quarterly cash flow from operations?
- What is the all time high quarterly CFO for ADC Therapeutics SA?
- What is ADC Therapeutics SA quarterly CFO year-on-year change?
- What is ADC Therapeutics SA TTM cash flow from operations?
- What is the all time high TTM CFO for ADC Therapeutics SA?
- What is ADC Therapeutics SA TTM CFO year-on-year change?
What is ADC Therapeutics SA annual cash flow from operations?
The current annual CFO of ADCT is -$118.69 M
What is the all time high annual CFO for ADC Therapeutics SA?
ADC Therapeutics SA all-time high annual cash flow from operations is -$74.94 M
What is ADC Therapeutics SA annual CFO year-on-year change?
Over the past year, ADCT annual cash flow from operations has changed by +$19.63 M (+14.19%)
What is ADC Therapeutics SA quarterly cash flow from operations?
The current quarterly CFO of ADCT is -$25.04 M
What is the all time high quarterly CFO for ADC Therapeutics SA?
ADC Therapeutics SA all-time high quarterly cash flow from operations is $2.19 M
What is ADC Therapeutics SA quarterly CFO year-on-year change?
Over the past year, ADCT quarterly cash flow from operations has changed by +$6.59 M (+20.83%)
What is ADC Therapeutics SA TTM cash flow from operations?
The current TTM CFO of ADCT is -$133.62 M
What is the all time high TTM CFO for ADC Therapeutics SA?
ADC Therapeutics SA all-time high TTM cash flow from operations is -$32.10 M
What is ADC Therapeutics SA TTM CFO year-on-year change?
Over the past year, ADCT TTM cash flow from operations has changed by -$14.93 M (-12.58%)